CLIP-Seq, eCLIP-Seq, DRIPc-Seq and Beyond: Choosing the Right RNA Interaction Profiling Method

The CLIP-seq Family and Where DRIPc-Seq Fits

Mapping RNA interactions is a central challenge in molecular biology, but the term "RNA interaction" encompasses fundamentally different molecular events — from RNA-binding proteins (RBPs) binding to specific transcripts, to R-loops forming where nascent RNA hybridizes back to template DNA. The methods used to probe these distinct biology questions differ in their crosslinking strategy, immunoprecipitation target, sequencing readout, and practical sample requirements.

The CLIP-seq (Crosslinking and Immunoprecipitation followed by Sequencing) family encompasses multiple variants sharing a core workflow: UV crosslinking stabilizes protein-RNA contacts, the RBP of interest is immunoprecipitated, co-purified RNA fragments are converted into a sequencing library, and the resulting reads map the protein's binding landscape (Hafner et al., 2021).

For background on CLIP-seq principles, see our CLIP-seq methodology overview.

DRIPc-seq (DNA:RNA Immunoprecipitation followed by cDNA conversion and sequencing) belongs in a different category. It uses the S9.6 monoclonal antibody, which recognizes DNA-RNA hybrid duplexes, to immunoprecipitate R-loop structures — three-stranded nucleic acid configurations where nascent RNA hybridizes back to template DNA (Sanz et al., 2016). DRIPc-seq is not a protein-centric method and should not be used for RBP binding studies. It answers the question: where do R-loops form genome-wide, and how does their distribution change under perturbation?

Experimental workflow comparison for HITS-CLIP, eCLIP, and DRIPc-seq, showing the distinct crosslinking strategies, immunoprecipitation targets, and sequencing readouts for protein-RNA vs DNA-RNA hybrid detection.

Standard CLIP-seq: When It Works and When It Doesn't

HITS-CLIP (often referred to simply as CLIP-seq) remains the foundational method in the family, with published validation across dozens of RBPs in human, mouse, and yeast systems.

Strengths

• Well-established protocols with extensive published validation
• Compatible with most commercially available RBP antibodies
• No metabolic labeling required — works with any cell type or tissue that can be UV-irradiated

Limitations

• High input requirement: 20–50 million cells. Prohibitive for primary cells, rare populations, or clinical specimens.
• High background: Gel-based size selection (30–60 nt) is operator-dependent and a major source of variability.
• PCR duplicates: Standard library amplification generates duplicate reads that must be computationally removed, potentially losing true binding signals.
• Antibody bottleneck: Many RBPs lack validated CLIP-grade antibodies.

eCLIP-seq: What It Adds Over Standard CLIP

Enhanced CLIP-seq was developed at the ENCODE consortium to address the reproducibility and input limitations of standard CLIP (Van Nostrand et al., 2016).

Key innovations

• Adapter ligation on-beads: Reduces handling losses and enables single-tube processing.
• Size-matched input controls: A matched non-immunoprecipitated RNA sample is processed in parallel, providing a quantitative background model that dramatically reduces false-positive peaks.
• Reduced input: 1–2 million cells — roughly a 20–50× reduction from standard CLIP-seq.

Practical advantages

• Plant compatibility: Validated for plant tissues where cell wall disruption and secondary metabolites challenge standard CLIP protocols.
• ENCODE reference data: Published eCLIP datasets for over 150 RBPs in K562 and HepG2 cells provide benchmarking references — for example, eCLIP profiles for FUS, TDP-43, hnRNPA1, MATR3, and TIA1 are publicly available from ENCODE accessions ENCSR907JNW–ENCSR981WKN (Van Nostrand et al., 2020).
• Reproducibility: The single-tube format reduces technical variability compared to multi-step standard CLIP protocols.

For a broader comparison across nucleic acid interaction profiling techniques, see our guide comparing ChIRP-seq, CLIP-seq, RIP, and related methods.

DRIPc-Seq: A Different Tool for a Different Question

DRIPc-seq addresses R-loop biology — three-stranded nucleic acid structures where nascent RNA hybridizes to template DNA — not protein-mediated interactions. The S9.6 antibody binds DNA-RNA hybrid duplexes with sub-nanomolar affinity, enabling immunoprecipitation of R-loop-containing genomic fragments under non-denaturing conditions.

What DRIPc-seq delivers

• Genome-wide, strand-specific R-loop maps at near-single-nucleotide resolution
• Quantification of R-loop abundance correlated with gene expression, chromatin state, and DNA sequence features
• Detection of condition-dependent R-loop changes (drug treatment, knockdown, stress)
• Compatibility with mammalian cell lines (MCF7, HeLa, K562) and primary tissue

Experimental design considerations

• Input requirement: 5–10 μg of high-quality genomic DNA per IP.
• Controls: RNase H treatment serves as a critical negative control — it specifically degrades the RNA strand of DNA-RNA hybrids, abrogating the S9.6 signal.
• Replicates: 2–3 biological replicates are standard, with 2 genotypes × 2 treatments × 2 replicates (8 samples total) being a common design.

Side-by-Side Method Comparison

Decision framework for selecting between CLIP-seq variants and DRIPc-seq based on the biological question, available input material, and required resolution.

Common Mistakes and How to Avoid Them

Comparative performance of CLIP-seq variants and DRIPc-seq across key experimental metrics: input requirement, mapping resolution, and background signal.

How to Choose: A Decision Framework

When to use standard CLIP-seq (HITS-CLIP)

• Abundant starting material is available (≥20 million cells)
• A validated CLIP-grade antibody exists for the RBP
• The goal is transcriptome-wide discovery of novel RBP binding sites

When to use eCLIP

• Input is limited: primary cells, sorted populations, clinical specimens
• Working with plant tissues or other challenging sample types
• ENCODE reference data (K562, HepG2) can serve as a benchmark for the same RBP

When to use PAR-CLIP or iCLIP

• Nucleotide-resolution crosslink site identification is the primary goal
• The RBP is amenable to 4SU metabolic labeling (PAR-CLIP only)
• The binding motif or crosslink preference is the central research question

When to use DRIPc-seq

• The question is about R-loop biology, not protein-RNA binding
• The goal is genome-wide mapping of DNA-RNA hybrid structures
• Screening for conditions that alter R-loop formation or resolution

For end-to-end support with RNA interaction profiling — including experimental design, library preparation, sequencing, and data analysis — our CLIP-seq and eCLIP-seq services provide validated workflows across mammalian and plant sample types.